Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Virology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
GENE THERAPY

Construction and Characterization of Hexon-Chimeric Adenoviruses: Specification of Adenovirus Serotype

Jason G. D. Gall, Ronald G. Crystal, Erik Falck-Pedersen
Jason G. D. Gall
Department of Microbiology, W. R. Hearst Research Foundation, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ronald G. Crystal
Department of Medicine, Cornell University Medical College, New York, New York 10021
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erik Falck-Pedersen
Department of Microbiology, W. R. Hearst Research Foundation, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JVI.72.12.10260-10264.1998
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Fig. 1.
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Construction of the hexon chimerasdlAd5NCAT-H2 and dlAd5NCAT-H2L2 by recombination. (A) Schematic and amino acid alignment of the Ad5 and Ad2 hexon proteins showing the locations of conserved regions (open bars) and hypervariable regions (HVR; gray bars) and the numbers of amino acid residues (aa) per region. Identity is shown as percent with the number of identical residues shown in parentheses. (B) Virus construction.dlAd5NCAT DNA was digested with either Bsu36I orDrdI to generate left- and right-hand-end subgenomic fragments, respectively. The fragments were cotransfected with linearized pH2-5. Shaded boxes, Ad5 hexon sequence; black boxes, regions of homology between the plasmid and the subgenomic fragments; thin lines, plasmid sequence. (C) Plasmid constructs for introducing mutations into the Ad5 hexon gene. Plasmid pH5 contains theHindIII-KpnI fragment (map units [m.u.] 51.03 to 61.81) of Ad5.

  • Fig. 2.
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Transduction of A549 lung cells by Ad hexon chimeras. (A) Schematics of the hexon proteins encoded by dlAd5NCAT,dlAd5NCAT-H2, and dlAd5NCAT-H2L2. Open bars, conserved sequence; black bars, Ad5 unique sequence; crosshatched bars, Ad2 unique sequence. (B) CAT activity in extracts of A549 cells infected with 10 or 100 particles of dlAd5NCAT,dlAd5NCAT-H2, or dlAd5NCAT-H2L2 per cell. CAT activity is expressed as the calculated total activity in the total extract. Values are means ± standard deviations of triplicates.

  • Fig. 3.
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    Effect of immunization with Ad hexon or fiber chimeras on the in vivo transduction efficiency of dlAd5NCAT. (A) Evaluation of the efficacy of intravenous administration. Adult female Sprague-Dawley rats were administered 1012 particles ofdlAd5NCAT-H2, dlAd5NCAT-H2L2, ordlAd5NCAT-F7 via the jugular vein, and the livers were assayed for CAT activity 3 days later. Data are the means of triplicates ± standard deviations. (B) Readministration. Adult female Sprague-Dawley rats were administered 1012particles of dlAd5NCAT-H2, dlAd5NCAT-H2L2, ordlAd5NCAT-F7 via the jugular vein. At 28 days postinfection, the same animals received 1012 particles ofdlAd5NCAT via the jugular vein and were sacrificed 24 h later, and their livers were processed for CAT activity assays. Values shown are a compilation of two independent experiments and are the means ± 1 standard deviation. Abbreviations: F7,dlAd5NCAT-F7; H2, dlAd5NCAT-H2; H2L2,dlAd5NCAT-H2L2.

Tables

  • Figures
  • Table 1.

    Neutralizing antibody titersa of hyperimmune sera

    VirusTiter of serumb
    Anti-Ad2Anti-Ad5Anti-dlAd5NCAT-H2Anti-dlAd5NCAT-H2L2
    Ad2>5,1200c 640160–320
    Ad50c 5,12040–802,560–5,120
    dlAd5NCAT-H21,280–2,560160–3206402,560
    dlAd5NCAT-H2L2405,120160–3205,120
    dlAd5NCAT-F7NDd 5,12040–805,120
    • ↵a Inverse of dilution giving 50% neutralization.

    • ↵b Serum sources: anti-Ad2 and anti-Ad5, ATCC (National Institute for Allergy and Infectious Diseases); anti-dlAd5NCAT-H2 and anti-dlAd5NCAT-H2L2, rat (without adjuvant).

    • ↵c No detectable neutralization.

    • ↵d Nd, not determined.

PreviousNext
Back to top
Download PDF
Citation Tools
Construction and Characterization of Hexon-Chimeric Adenoviruses: Specification of Adenovirus Serotype
Jason G. D. Gall, Ronald G. Crystal, Erik Falck-Pedersen
Journal of Virology Dec 1998, 72 (12) 10260-10264; DOI: 10.1128/JVI.72.12.10260-10264.1998

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Virology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Construction and Characterization of Hexon-Chimeric Adenoviruses: Specification of Adenovirus Serotype
(Your Name) has forwarded a page to you from Journal of Virology
(Your Name) thought you would be interested in this article in Journal of Virology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Construction and Characterization of Hexon-Chimeric Adenoviruses: Specification of Adenovirus Serotype
Jason G. D. Gall, Ronald G. Crystal, Erik Falck-Pedersen
Journal of Virology Dec 1998, 72 (12) 10260-10264; DOI: 10.1128/JVI.72.12.10260-10264.1998
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

capsid
Capsid Proteins
Chimera
mastadenovirus

Related Articles

Cited By...

About

  • About JVI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #Jvirology

@ASMicrobiology

       

 

JVI in collaboration with

American Society for Virology

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0022-538X; Online ISSN: 1098-5514